Blog
RSS FeedPosted by Michael Wonder on 24 Jan 2023
Reform Medicare to sustain system
25 January 2023 - Australia’s hybrid public/private healthcare system, including the principle of universal coverage through Medicare, has served the nation ...
Posted by Michael Wonder on 20 Jan 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee
20 January 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee held its first two meetings on 1 ...
Posted by Michael Wonder on 20 Jan 2023
Consultation on the revised PBS post-market review framework – publication of responses
20 January 2023 - Consultation on a revised draft of the PBS post-market review framework was open from 20 October ...
Posted by Michael Wonder on 18 Jan 2023
FDA’s breakthrough program: faster drug OKs without sacrificing safety
18 January 2023 - A FDA program markedly cut the time and cost of bringing to market new drugs, without ...
Posted by Michael Wonder on 15 Jan 2023
PHARMAC's year in review leaves much to be desired
1 January 2023 - Christmas came early for a number of long-suffering patients. ...
Posted by Michael Wonder on 11 Jan 2023
Prescription drug policy, 2022 and 2023: the year in review and the year ahead
9 January 2023 - This past year featured many significant developments in the prescription drug policy area, most notably the passage ...
Posted by Michael Wonder on 21 Nov 2022
FDA cancer chief wants quicker ways to pull failed drugs
17 November 2022 - Makena highlights need to make system more nimble. ...
Posted by Michael Wonder on 18 Nov 2022
Medicines industry calls for discount rate reduction now
18 November 2022 - Medicines Australia welcomes the recommendation to lower the discount rate for medicines and vaccines but questions ...
Posted by Michael Wonder on 06 Nov 2022
Independent review into Medicare compliance
5 November 2022 - The Albanese Government has appointed respected health economist Dr Pradeep Philip to conduct an independent review into ...
Posted by Michael Wonder on 27 Oct 2022
Health technology assessment review – frequently asked questions
27 October 2022 - The Department of Health & Aged Care has produced a two page summary on the upcoming ...
Posted by Michael Wonder on 27 Oct 2022
Independent chair of health technology assessment review will drive major reform of Australia’s health system
27 October 2022 - Medicines Australia welcomes the appointment of Adjunct Professor Debora Picone AO as independent Chair of the ...
Posted by Michael Wonder on 27 Oct 2022
Reference Committee for the health technology assessment policy and methods review
27 October 2022 - On 6 September 2021, the Commonwealth entered into a new Strategic Agreement in relation to reimbursement, ...
Posted by Michael Wonder on 27 Oct 2022
HTA review and chair committee
27 October 2022 - The Government today announced the appointment of Adjunct Professor Debora Picone AO as Chair of the Health ...
Posted by Michael Wonder on 25 Oct 2022
Reforming the World Health Organization’s Essential Medicines List: essential but unaffordable
24 October 2022 - The Model List of Essential Medicines of the World Health Organization highlights medicines considered the most ...
Posted by Michael Wonder on 20 Oct 2022
ICER evaluates drug price increases in California
20 October 2022 - Unsupported Price Increase” final report based on drugs identified through SB-17, the California drug price transparency law. ...